Dr. Furhan Yunus, MD

Dr. Yunus practices at North Baldwin Infirmary in Bay Minette, Alabama, part of Infirmary Health.

Dr. Yunus' NPI, 1326048356, was assigned on August 1, 2005. Dr. Yunus graduated from King Edward Medical University in 1987. Dr. Yunus holds Louisiana license MD.207786.

Dr. Yunus' primary practice is North Baldwin Infirmary, at 1815 Hand Avenue, Bay Minette, AL 36507 in Baldwin County. The practice phone is (251) 937-5521.

Dr. Yunus' primary practice is North Baldwin Infirmary in Bay Minette, Alabama, part of Infirmary Health. Dr. Yunus is also affiliated with Mobile Infirmary. The medical group on file is Diagnostic & Medical Clinic. Dmand AI also links Dr. Yunus to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yunus practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Yunus' primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Yunus is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Yunus' licenses on file in 7 states: Louisiana, Alabama, Mississippi, Tennessee, Pennsylvania, Arkansas and Arizona.

Dmand AI lists breast cancer, chronic anemia, chronic leukemia, colorectal cancer, immune deficiency disease, lung cancer, lymphoma and multiple myeloma among the conditions Dr. Yunus treats.

CMS data shows 2,096 Medicare services from Dr. Yunus across 20 procedure codes in 2024, for 322 Medicare patients. Medicare paid $82,161 for them.

CMS counts 322 Medicare patients who saw Dr. Yunus in 2024. The largest group is 65 to 74, with 139 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 13% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yunus' median patient age at 71, with 54% women.

In 2024, Dr. Yunus wrote 2,331 Medicare Part D claims for 319 patients. 83% of them were for generic drugs. CMS names the drug for 1,941 of them, across 58 drugs with 11 or more claims each, at $2,973,159 in total drug cost. In 2023, CMS named 1,851 claims across 55 drugs.

Dr. Yunus accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yunus as offering telehealth.

Dmand AI links 4 papers to Dr. Yunus, published from 2012 to 2014. Dr. Yunus' most frequent co-authors are Bruce Earl Brockstein, MD, Ranee Mehra, MD and Mark Agulnik, MD.

Dmand AI links Dr. Yunus to 4 clinical trials, 2 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Melanoma, Nevi and Melanomas and Smoldering Multiple Myeloma. National Cancer Institute (NCI) sponsors the most, 4.

CMS Open Payments shows 501 general payments to Dr. Yunus from 55 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 65% of the total. Genentech, Inc. paid the most, $135,247. It also lists 13 research payments totaling $8,602 from 2019 to 2025.

Dr. Yunus graduated from King Edward Medical University in 1987.

Dr. Yunus is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.